Acurx Pharmaceuticals

-$0.06 (-2.22%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACXP and other ETFs, options, and stocks.

About ACXP

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme.

CEO
David P. Luci
Employees
3
Headquarters
New York, New York
Founded
2017

ACXP Key Statistics

Market cap
27.09M
Price-Earnings ratio
—
Dividend yield
—
Average volume
21.24K
High today
$2.88
Low today
$2.69
Open price
$2.75
Volume
4.54K
52 Week high
$8.74
52 Week low
$2.59

ACXP Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.33 per share
Actual
-$0.26 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure